학술논문
Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer.
Document Type
Article
Source
Subject
*INFLAMMATION
*PLATINUM
*DRUG therapy
*SMALL cell lung cancer
*LUNG cancer
*PROGNOSIS
*
*
*
*
*
Language
ISSN
0007-0920
Abstract
The value of an inflammation-based prognostic score (GPS) was compared with performance status (ECOG) in patients (n=109) receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. On multivariate analysis with ECOG, white cell count and the GPS entered as covariates, only the GPS was a significant independent predictor of survival (HR 1.88, 95% CI 1.25-2.84, P=0.002).British Journal of Cancer (2004) 90, 1704-1706. doi:10.1038/sj.bjc.6601789 www.bjcancer.com Published online, 13 April 2004 [ABSTRACT FROM AUTHOR]